Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant Recipients
NCT00137748
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Hypogammaglobulinemia
Interventions
DRUG:
CMV-Ig
Sponsor
The Cleveland Clinic